Publication | Open Access
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma
122
Citations
27
References
2012
Year
Phase I study showed that intraventricular rituximab plus methotrexate is feasible and active in the treatment of refractory CNS lymphoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1